Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Chronic lung allograft rejection: mechanisms and therapy Belperio JA; Weigt SS; Fishbein MC; Lynch JP 3rdProc Am Thorac Soc 2009[Jan]; 6 (1): 108-21Lung transplantation is a therapeutic option for patients with end-stage pulmonary disorders. Unfortunately, due to post-lung transplant complications, both infectious and noninfectious, it is only a treatment and not a cure. Importantly, despite induction combined with triple or quadruple maintenance immunosuppressive therapy, chronic lung rejection, in the form of obliterative bronchiolitis or its clinical correlate bronchiolitis obliterans syndrome (BOS), continues to be highly prevalent and is the major limitation to long-term survival. In this review we evaluate the presentation, diagnosis, histopathology, pathologic mechanisms, risk factors, and prevention/treatment options for BOS. A better understanding of the risk factors and how it relates to the pathologic mechanisms of chronic lung allograft rejection should lead to better pharmacologic targets to prevent/treat this syndrome without increasing the recipient's risk for infections.|*Lung Transplantation[MESH]|Antibody Formation[MESH]|Bronchiolitis Obliterans/diagnosis/etiology/*immunology/therapy[MESH]|Bronchoscopy[MESH]|Chronic Disease[MESH]|Cytokines/immunology[MESH]|Graft Rejection/*immunology[MESH]|Humans[MESH]|Intercellular Signaling Peptides and Proteins/immunology[MESH]|Risk Factors[MESH]|Transplantation, Homologous[MESH] |
